By Robb M. Stewart MELBOURNE, Australia--BHP Group Ltd. (BHP.AU) has flagged a number of projects that could boost its oil production and help the global miner meet a supply gap that it...
International stocks trading in New York closed slightly higher on Thursday. The BNY Mellon index of American depositary receipts rose 0.7% to 157.42. The European index increased 0.7% to 145.14...
Benitec Establishes A Sponsored US ADR Program PR Newswire SYDNEY, May 30, 2014 SYDNEY, May 30, 2014 /PRNewswire/ -- Benitec Biopharma Limited (ASX: BLT) (OTC: BTEBY) is pleased to announce the...
Benitec Commences Patient Dosing With TT-034 In Patients With Hepatitis C PR Newswire SYDNEY, May 29, 2014 SYDNEY, May 29, 2014 /PRNewswire/ -- RNAi-based therapeutics company, Benitec Biopharma...
European Patents Update PR Newswire THE HAGUE, The Netherlands, May 22, 2014 -- Outcome of EPO opposition hearing -- Benitec executes license from Galapagos NV for RNAi in Europe THE HAGUE, The...
European Patents Update -- Outcome of EPO opposition hearing -- Benitec executes license from Galapagos NV for RNAi in Europe PR Newswire THE HAGUE, The Netherlands, May 22, 2014 THE HAGUE, The...
Benitec Biopharma Completes AUD $31.5 million Private Placement Shareholders Overwhelmingly Approve Second AUD $15.7 million Tranche Following General Meeting PR Newswire SYDNEY, April 15, 2014...
Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants Company to Receive up to approximately AUD $31.5 million to Accelerate Clinical Development TT-034 for Treating...
HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC) -- Benitec progresses hepatitis C therapeutic towards the clinic -- Application for RAC review of hepatitis C...
Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections PR Newswire SYDNEY, April 15, 2013 SYDNEY, April 15...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | -0.01 | -27.7777777778 | 0.036 | 0.051 | 0.022 | 798240 | 0.03753944 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.